Patient Rights in Health Insurance Coverage Disputes

Health insurance coverage disputes arise when a payer denies, reduces, or delays payment for medical services a patient received or seeks to receive. Federal statutes including the Affordable Care Act (ACA), the Employee Retirement Income Security Act (ERISA), and the No Surprises Act establish a structured set of procedural rights that govern how patients can challenge these decisions. This page maps those rights, the regulatory frameworks that define them, and the practical mechanics of the internal and external appeal processes that insurers and patients must follow.

• Definition and scope
• Core mechanics or structure
• Causal relationships or drivers
• Classification boundaries
• Tradeoffs and tensions
• Common misconceptions
• Checklist or steps (non-advisory)
• Reference table or matrix
• References

Definition and scope

A coverage dispute in the health insurance context is a formal disagreement between a patient (or their provider) and an insurer about whether a specific service, drug, device, or episode of care falls within the terms of the insurance contract and applicable law. Coverage disputes are distinct from billing errors (which involve coding or administrative mistakes) and from medical billing rights, which govern the accuracy and transparency of charges rather than payer eligibility decisions.

The federal regulatory scope of coverage dispute rights depends on the type of health plan:

• ACA marketplace plans and fully insured employer-sponsored plans are governed primarily by 42 U.S.C. §§ 300gg-1 through 300gg-63 and implementing regulations at 45 C.F.R. Part 147.
• Self-funded employer plans fall under ERISA (29 U.S.C. § 1001 et seq.), which preempts most state insurance regulations and grants participants rights to appeal benefit denials under 29 C.F.R. § 2560.503-1.
• Medicare Advantage disputes follow CMS appeal procedures under 42 C.F.R. Part 422, Subpart M.
• Medicaid managed care appeals are governed by 42 C.F.R. Part 438, Subpart F, as amended effective February 25, 2026. The February 25, 2026 amendments to 42 C.F.R. Part 438 introduced updated requirements applicable to Medicaid managed care organizations, including revised grievance and appeal procedures, updated timeframe and notice standards, and strengthened enrollee rights protections. Covered entities are required to align their policies, grievance and appeal procedures, and documentation standards with the amended regulatory text as currently in force, rather than any superseded version. Documentation standards must reflect the current regulatory text, and compliance obligations are enforceable as of the applicable compliance date established in the final rule. Survey and enforcement activity references the amended standard as of the applicable compliance date, not merely the effective date of February 25, 2026.

The patient rights described here do not extend automatically to short-term limited-duration insurance plans, which are exempt from most ACA consumer protections under 45 C.F.R. § 144.103.

Core mechanics or structure

The Two-Stage Appeal Framework

Federal rules require most regulated health plans to provide at least two tiers of formal review before a patient must seek external relief.

Stage 1 — Internal Appeal
Under 45 C.F.R. § 147.136, non-grandfathered group and individual health plans must complete an internal appeal within:
- 72 hours for urgent/expedited pre-service claims
- 30 days for non-urgent pre-service claims
- 60 days for post-service claims

The plan must provide written notice of the denial including the specific reason, the plan provision relied upon, and a description of the internal review process.

Stage 2 — External Review
Upon exhaustion or deemed exhaustion of internal appeals, patients have the right to request Independent External Review (IER). The ACA mandated federal standards for external review at 45 C.F.R. § 147.138, requiring review by an accredited Independent Review Organization (IRO). Decisions by IROs are binding on the insurer. Federal standards apply to ERISA self-insured plans without a state external review law, administered by the Department of Labor under Technical Release 2011-04.

For Medicare Advantage enrollees, the 5-level appeal process runs through: plan-level redetermination → Qualified Independent Contractor (QIC) reconsideration → Office of Medicare Hearings and Appeals (OMHA) → Medicare Appeals Council → Federal District Court. Federal court jurisdiction attaches when the amount in controversy reaches $1,870 (2024 threshold) (CMS Medicare Appeals).

Causal relationships or drivers

Coverage denials arise from a finite set of triggering conditions:

1. Medical necessity determinations — The plan's utilization management contractor concludes that a service does not meet clinical criteria. Insurers often use proprietary criteria (such as MCG Health or InterQual guidelines), which are not always publicly disclosed.
2. Network status disputes — A provider is billed as out-of-network, or the patient received emergency care from an out-of-network facility. The No Surprises Act (enacted as Division BB of the Consolidated Appropriations Act, 2021, Pub. L. 116-260, signed into law December 27, 2020) added federal protections against unexpected out-of-network charges effective January 1, 2022, and created an Independent Dispute Resolution (IDR) process.
3. Prior authorization failures — A service was rendered without required pre-approval, or a prior authorization request was denied. CMS issued a final rule in 2024 requiring certain federal payers to implement standardized electronic prior authorization APIs by January 2027 (CMS Interoperability and Prior Authorization Final Rule, CMS-0057-F).
4. Benefit exclusions — The plan contract explicitly excludes the service (e.g., cosmetic procedures, experimental treatments).
5. Coordination of Benefits (COB) conflicts — When a patient carries dual coverage, a dispute over which insurer pays first can result in both plans declining primary responsibility.

Understanding which driver produced a denial is essential because the applicable appeal standard, timeline, and review criteria differ by type. For disputes touching on surprise billing patient protections, the IDR pathway applies rather than standard internal appeal.

Classification boundaries

Not every insurance-related patient complaint constitutes a "coverage dispute" with appeal rights. The following classification distinctions matter for identifying which remedies apply:

The patient rights overview provides broader context for where coverage dispute rights sit within the full spectrum of patient protections. Coverage disputes are procedurally distinct from grievances about the quality of care received, which are governed by separate grievance procedures under 42 C.F.R. § 438.400 (Medicaid) and 42 C.F.R. § 422.564 (Medicare Advantage).

Tradeoffs and tensions

ERISA preemption versus state consumer protections
Self-funded employer plans — which covered approximately 65% of privately insured workers in 2023 (Kaiser Family Foundation Employer Health Benefits Survey 2023) — are shielded from state insurance mandates under ERISA § 514 (29 U.S.C. § 1144). This means patients in self-funded plans cannot invoke state external review laws or state prompt-pay statutes. Federal external review standards under the ACA partially fill this gap, but enforcement mechanisms are weaker than under state-regulated plans.

Proprietary medical necessity criteria
Insurers commonly apply clinical guidelines developed by private vendors rather than published professional society standards. Courts and regulators have increasingly scrutinized this practice. California's Department of Managed Health Care, for example, issued guidance requiring plans to use "generally accepted standards of medical practice" rather than internally developed utilization criteria — a tension that the federal Mental Health Parity and Addiction Equity Act (MHPAEA) (29 U.S.C. § 1185a) has sharpened for behavioral health.

Expedited review timelines versus thoroughness
The 72-hour window for urgent appeals limits the depth of clinical review possible before a decision must issue. Plans may issue technically compliant but clinically thin denials within the window, placing the evidentiary burden on the patient's treating physician to rebut in a subsequent external review.

Cost-sharing exposure during appeals
Patients who receive care while an appeal is pending may accumulate out-of-pocket liability. Federal rules do not generally require plans to hold cost-sharing in abeyance during the appeal period unless an injunction is obtained under ERISA § 502(a) (29 U.S.C. § 1132(a)).

Common misconceptions

Misconception 1: "A denial letter means the claim is final."
Federal law requires that all denial notices include information about the right to appeal. Receipt of a denial triggers — not closes — the appeal rights window. Under 45 C.F.R. § 147.136(d), plans must provide at least 180 days from the denial to file an internal appeal.

Misconception 2: "External review is only available after losing the internal appeal."
Federal rules permit patients to bypass the internal appeal and proceed directly to external review in cases of "deemed exhaustion" — when a plan fails to follow required internal appeal procedures. This is codified at 45 C.F.R. § 147.136(b)(2)(ii)(F).

Misconception 3: "ERISA plans cannot be challenged in court."
ERISA § 502(a) (29 U.S.C. § 1132(a)) permits participants to bring civil actions to recover benefits due or to enforce plan terms. Judicial review applies, though federal courts review most ERISA benefit denials under an "arbitrary and capricious" standard when the plan confers discretion on the administrator, which is a deferential standard that favors the plan.

Misconception 4: "The No Surprises Act eliminated all out-of-network patient liability."
The Act limits cost-sharing for emergency services and certain non-emergency services at in-network facilities to in-network levels (45 C.F.R. § 149.410), but it does not apply to all out-of-network scenarios. Scheduled, non-emergency care at out-of-network facilities — where the patient provided prior written consent — remains subject to out-of-network cost-sharing. The filing a patient grievance process is a separate channel for complaints about surprise billing violations.

Misconception 5: "Medicare Advantage denials follow the same process as original Medicare."
Original Medicare Part A and Part B appeals are administered by the Medicare Administrative Contractors and OMHA. Medicare Advantage (Part C) denials must first go through the plan's own internal process before reaching the QIC level. Timelines, forms, and governing regulations differ.

Checklist or steps (non-advisory)

The following steps describe the procedural sequence established by federal regulations for patients navigating a coverage denial. This is a reference description of the regulatory process — not guidance on any individual situation.

Step 1 — Obtain the Explanation of Benefits (EOB) and denial notice
Plans must provide a written explanation of each denial, including the specific plan provision, clinical rationale if applicable, and the identity of qualified professionals (45 C.F.R. § 147.136(d)(2)).

Step 2 — Identify the type of plan
Determine whether the plan is ACA marketplace, ERISA self-funded, Medicare Advantage, or Medicaid managed care. This controls which appeal rules and timelines apply.

Step 3 — Request the complete claim file
Under 29 C.F.R. § 2560.503-1(h)(2)(iii), ERISA plans must provide all documents, records, and other information relevant to the claim upon request, free of charge.

Step 4 — File the internal appeal within the deadline
The ACA requires a minimum 180-day window from receipt of the denial for internal appeal. Medicare Advantage enrollees have 60 days to request plan-level redetermination.

Step 5 — Submit clinical documentation
The appeal should include the treating physician's medical rationale, relevant clinical literature, and documentation that contradicts the basis for denial (e.g., evidence that the service meets accepted clinical standards).

Step 6 — Request expedited review if clinically urgent
If the standard timeline would seriously jeopardize the patient's health, a request for expedited internal or external review must be processed within 72 hours (45 C.F.R. § 147.136(c)(2)).

Step 7 — File for external review upon exhaustion
Once the internal appeal is denied or deemed exhausted, a request for external review must be submitted. Federal rules set a 4-month deadline for filing external review requests following a final internal denial (45 C.F.R. § 147.138(b)(1)(ii)).

Step 8 — Document all communications
Maintain records of all correspondence, submission confirmations, and plan responses, as these form the evidentiary record for any subsequent judicial review under ERISA or state law.

Reference table or matrix

Federal Appeal Rights by Plan Type